Report cover image

Global Apremilast Tablets Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 198 Pages
SKU # APRC20279321

Description

Summary

According to APO Research, the global Apremilast Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Apremilast Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Apremilast Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Apremilast Tablets market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Apremilast Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Apremilast Tablets market include CSPC Ouyi Pharmaceutical, Shanghai Modern Pharmaceutical, Qilu Pharmaceutical, Glenmark Pharmaceuticals and Amgen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Apremilast Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Apremilast Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Apremilast Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Apremilast Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Apremilast Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Apremilast Tablets sales, projected growth trends, production technology, application and end-user industry.

Apremilast Tablets Segment by Company

CSPC Ouyi Pharmaceutical
Shanghai Modern Pharmaceutical
Qilu Pharmaceutical
Glenmark Pharmaceuticals
Amgen
Apremilast Tablets Segment by Type

10mg/Tablet
20mg/Tablet
30mg/Tablet
Apremilast Tablets Segment by Application

Hospital Pharmacy
Retail Pharmacy
Apremilast Tablets Segment by Region

North America

United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Apremilast Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Apremilast Tablets market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Apremilast Tablets significant trends, drivers, influence factors in global and regions.
6. To analyze Apremilast Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apremilast Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Apremilast Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apremilast Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Apremilast Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Apremilast Tablets industry.
Chapter 3: Detailed analysis of Apremilast Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Apremilast Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Apremilast Tablets in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Apremilast Tablets Sales Value (2020-2031)
1.2.2 Global Apremilast Tablets Sales Volume (2020-2031)
1.2.3 Global Apremilast Tablets Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Apremilast Tablets Market Dynamics
2.1 Apremilast Tablets Industry Trends
2.2 Apremilast Tablets Industry Drivers
2.3 Apremilast Tablets Industry Opportunities and Challenges
2.4 Apremilast Tablets Industry Restraints
3 Apremilast Tablets Market by Company
3.1 Global Apremilast Tablets Company Revenue Ranking in 2024
3.2 Global Apremilast Tablets Revenue by Company (2020-2025)
3.3 Global Apremilast Tablets Sales Volume by Company (2020-2025)
3.4 Global Apremilast Tablets Average Price by Company (2020-2025)
3.5 Global Apremilast Tablets Company Ranking (2023-2025)
3.6 Global Apremilast Tablets Company Manufacturing Base and Headquarters
3.7 Global Apremilast Tablets Company Product Type and Application
3.8 Global Apremilast Tablets Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Apremilast Tablets Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Apremilast Tablets Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Apremilast Tablets Market by Type
4.1 Apremilast Tablets Type Introduction
4.1.1 10mg/Tablet
4.1.2 20mg/Tablet
4.1.3 30mg/Tablet
4.2 Global Apremilast Tablets Sales Volume by Type
4.2.1 Global Apremilast Tablets Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Apremilast Tablets Sales Volume by Type (2020-2031)
4.2.3 Global Apremilast Tablets Sales Volume Share by Type (2020-2031)
4.3 Global Apremilast Tablets Sales Value by Type
4.3.1 Global Apremilast Tablets Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Apremilast Tablets Sales Value by Type (2020-2031)
4.3.3 Global Apremilast Tablets Sales Value Share by Type (2020-2031)
5 Apremilast Tablets Market by Application
5.1 Apremilast Tablets Application Introduction
5.1.1 Hospital Pharmacy
5.1.2 Retail Pharmacy
5.2 Global Apremilast Tablets Sales Volume by Application
5.2.1 Global Apremilast Tablets Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Apremilast Tablets Sales Volume by Application (2020-2031)
5.2.3 Global Apremilast Tablets Sales Volume Share by Application (2020-2031)
5.3 Global Apremilast Tablets Sales Value by Application
5.3.1 Global Apremilast Tablets Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Apremilast Tablets Sales Value by Application (2020-2031)
5.3.3 Global Apremilast Tablets Sales Value Share by Application (2020-2031)
6 Apremilast Tablets Regional Sales and Value Analysis
6.1 Global Apremilast Tablets Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Apremilast Tablets Sales by Region (2020-2031)
6.2.1 Global Apremilast Tablets Sales by Region: 2020-2025
6.2.2 Global Apremilast Tablets Sales by Region (2026-2031)
6.3 Global Apremilast Tablets Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Apremilast Tablets Sales Value by Region (2020-2031)
6.4.1 Global Apremilast Tablets Sales Value by Region: 2020-2025
6.4.2 Global Apremilast Tablets Sales Value by Region (2026-2031)
6.5 Global Apremilast Tablets Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Apremilast Tablets Sales Value (2020-2031)
6.6.2 North America Apremilast Tablets Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Apremilast Tablets Sales Value (2020-2031)
6.7.2 Europe Apremilast Tablets Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Apremilast Tablets Sales Value (2020-2031)
6.8.2 Asia-Pacific Apremilast Tablets Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Apremilast Tablets Sales Value (2020-2031)
6.9.2 South America Apremilast Tablets Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Apremilast Tablets Sales Value (2020-2031)
6.10.2 Middle East & Africa Apremilast Tablets Sales Value Share by Country, 2024 VS 2031
7 Apremilast Tablets Country-level Sales and Value Analysis
7.1 Global Apremilast Tablets Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Apremilast Tablets Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Apremilast Tablets Sales by Country (2020-2031)
7.3.1 Global Apremilast Tablets Sales by Country (2020-2025)
7.3.2 Global Apremilast Tablets Sales by Country (2026-2031)
7.4 Global Apremilast Tablets Sales Value by Country (2020-2031)
7.4.1 Global Apremilast Tablets Sales Value by Country (2020-2025)
7.4.2 Global Apremilast Tablets Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.5.2 USA Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.6.2 Canada Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.8.2 Germany Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.9.2 France Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.9.3 France Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.11.2 Italy Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.12.2 Spain Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.13.2 Russia Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.16.2 China Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.16.3 China Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.17.2 Japan Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.19.2 India Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.19.3 India Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.20.2 Australia Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.24.2 Chile Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.26.2 Peru Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.28.2 Israel Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.29.2 UAE Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.31.2 Iran Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Apremilast Tablets Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Apremilast Tablets Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Apremilast Tablets Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 CSPC Ouyi Pharmaceutical
8.1.1 CSPC Ouyi Pharmaceutical Comapny Information
8.1.2 CSPC Ouyi Pharmaceutical Business Overview
8.1.3 CSPC Ouyi Pharmaceutical Apremilast Tablets Sales, Value and Gross Margin (2020-2025)
8.1.4 CSPC Ouyi Pharmaceutical Apremilast Tablets Product Portfolio
8.1.5 CSPC Ouyi Pharmaceutical Recent Developments
8.2 Shanghai Modern Pharmaceutical
8.2.1 Shanghai Modern Pharmaceutical Comapny Information
8.2.2 Shanghai Modern Pharmaceutical Business Overview
8.2.3 Shanghai Modern Pharmaceutical Apremilast Tablets Sales, Value and Gross Margin (2020-2025)
8.2.4 Shanghai Modern Pharmaceutical Apremilast Tablets Product Portfolio
8.2.5 Shanghai Modern Pharmaceutical Recent Developments
8.3 Qilu Pharmaceutical
8.3.1 Qilu Pharmaceutical Comapny Information
8.3.2 Qilu Pharmaceutical Business Overview
8.3.3 Qilu Pharmaceutical Apremilast Tablets Sales, Value and Gross Margin (2020-2025)
8.3.4 Qilu Pharmaceutical Apremilast Tablets Product Portfolio
8.3.5 Qilu Pharmaceutical Recent Developments
8.4 Glenmark Pharmaceuticals
8.4.1 Glenmark Pharmaceuticals Comapny Information
8.4.2 Glenmark Pharmaceuticals Business Overview
8.4.3 Glenmark Pharmaceuticals Apremilast Tablets Sales, Value and Gross Margin (2020-2025)
8.4.4 Glenmark Pharmaceuticals Apremilast Tablets Product Portfolio
8.4.5 Glenmark Pharmaceuticals Recent Developments
8.5 Amgen
8.5.1 Amgen Comapny Information
8.5.2 Amgen Business Overview
8.5.3 Amgen Apremilast Tablets Sales, Value and Gross Margin (2020-2025)
8.5.4 Amgen Apremilast Tablets Product Portfolio
8.5.5 Amgen Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Apremilast Tablets Value Chain Analysis
9.1.1 Apremilast Tablets Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Apremilast Tablets Sales Mode & Process
9.2 Apremilast Tablets Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Apremilast Tablets Distributors
9.2.3 Apremilast Tablets Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.